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Phosphorylcholine, a crucial component of the pneumococcal
cell wall, is essential in bacterial physiology and in human
pathogenesis because it binds to serum components of the
immune system and acts as a docking station for the family of
surface choline-binding proteins. The three-dimensional structure
of choline-binding protein F (CbpF), one of the most abundant
proteins in the pneumococcal cell wall, has been solved in
complex with choline. CbpF shows a new modular structure
composed both of consensus and non-consensus choline-binding
repeats, distributed along its length, which markedly alter its
shape, charge distribution and binding ability, and organizing the
protein into two well-defined modules. The carboxy-terminal
module is involved in cell wall binding and the amino-terminal
module is crucial for inhibition of the autolytic LytC muramidase,
providing a regulatory function for pneumococcal autolysis.
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INTRODUCTION
The Gram-positive bacterium Streptococcus pneumoniae is one of
the most important human pathogens, which is commensal to the
nasopharyngeal cavity. However, under appropriate conditions,
pneumococci are able to cause invasive infections such as
sepsis and meningitis (Cartwright, 2002). S. pneumoniae is unique
among prokaryotes due to an absolute requirement for choline in
growth, which is incorporated as phosphorylcholine into the
cell wall teichoic acid and the membrane lipoteichoic acid
(Tomasz, 1967). Choline is recognized by components of the host
innate immune system, such as C-reactive protein and the
receptor of the platelet-activating factor (Cundell et al, 1995).
In addition, choline anchors a special class of pneumococcal
proteins, referred to as choline-binding proteins (CBPs), to the
cell wall by non-covalent interactions. These proteins are involved
in a wide range of physiological functions, particularly adhesion
to human cells (PspA, CbpA and CbpG; Bergmann & Ham-
merschmidt, 2006), as cell wall lytic enzymes (LytA, LytB, LytC
and Pce; Lo´pez & Garcı´a, 2004), or in competence for genetic
transformation (LytA, LytC and CbpD; Claverys & Havarstein,
2007). Many of these surface proteins are virulence factors that
contribute to the pathogenesis of this organism. CBPs share a
modular organization consisting of a biologically active domain
and a conserved choline-binding module (CBM). So far, full-
length three-dimensional structures of CBPs are available for the
phage-encoded lysozyme Cpl-1 (Hermoso et al, 2003) and
pneumococcal Pce (Hermoso et al, 2005).
Here, we describe, for the first time, the crystal structure of
CbpF, a member of a new subfamily of the CBPs that are strictly
composed of a combination of canonical and non-conserved
choline-binding motifs. CbpF is divided into two differentiated
modules with specific mechanistic roles. Biochemical studies
show that CbpF modulates the enzymatic activity of pneumococcal
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murein hydrolases, suggesting that this CBP could be essential in the
regulation of these crucial enzymes.
RESULTS AND DISCUSSION
Overall structure of the CbpF–choline complex
CbpF was crystallized, and its structure was solved by the single-
wavelength anomalous diffraction (SAD) technique. CbpF is
folded into two well-defined modules (Fig 1). The amino-terminal
module (residues 1–128) shows a disc-shape conformation
(37 A˚ 34 A˚ 24 A˚). The CBM (residues 129–311) follows the
superhelical fold previously found in other CBPs and is arranged
into two regions referred to as CI and CII (Fig 1A). The CII domain
(residues 193–311) presents five choline-binding repeats (p1–p5)
of around 20 amino acids each, with the consensus motif (GWXK-
X45-WYY-hydrophobic-X35-GXMX23), and a carboxy-terminal
tail of 16 amino acids (295–311). Each repeat comprises a
symmetrical b-hairpin, followed by a loop and a coiled region.
The CI structural domain of CbpF (residues 129–192) presents two
modified choline-binding repeats (dp5 and dp6) showing addi-
tional amino acids inside the b-hairpin of the dp6 repeat and also
in the loop after the b-hairpin of the dp5 repeat (coloured in red
and cyan in Fig 1B). The CI domain defines a linker region
between the N-terminal module and the CBM.
The structure of CbpF has unique features compared with other
CBPs, as it is assembled entirely by choline-binding repeats. In
the CII domain, the repeats strictly follow the consensus motif,
whereas in the CI domain they are moderately modified by amino-
acid insertions. Notably, the repeats building the N-terminal
module are highly modified by both additional amino acids and
mutations on different positions of the consensus motif (see
Fig 1B). The presence of this choline-binding repeat framework
along the sequence produces the elongated shape of CbpF
(4117 A˚ long) and results in a good structural superimposition
of both canonical and modified repeats (Fig 1C).
The crystal structure of CbpF in complex with choline shows
that up to seven choline-binding sites are available (Fig 1). These
seven choline molecules are all located at the CBM in such a way
that at least three structurally conserved aromatic residues (two
tryptophans from a repeat and one tyrosine from the next repeat)
plus one hydrophobic residue (methionine or leucine) form a
cavity in which choline methyl groups are placed (Fig 2A). This
binding-site framework is observed in both CI and CII domains;
however, the N-terminal module does not fulfil the choline-
binding requirements. We note that in dp1, dp2 and dp4 repeats at
least one of the crucial tryptophan residues is replaced by
threonine or lysine (Fig 1B). It would seem that this mutational
replacement of residues produces a reduction in choline-binding
ability and that, in the case of the lysine residues, the formation of
crucial salt bridge interactions affects modular rearrangement
(see below).
Sequence divergence in the choline-binding repeats
Sequence divergence observed in CbpF is generated by mutations
of the consensus amino-acid residues of the repeat, by amino-acid
additions in the b-hairpin turn or the loop, or by a combination
of both (Fig 1B). The high divergence of the first four repeats (dp1–
dp4) is responsible for the absence of choline-binding capacity at
the N-terminal region. Besides, modifications in the nature and
composition of the choline-binding repeats crucially alter other
features of CbpF. Amino-acid additions observed in dp3, dp4, dp5
and dp6 repeats (Fig 1B) result in longer repeats of 43, 39, 32 and
30 amino acids, respectively, compared with the 20 amino acids
of a canonical choline-binding repeat. Variations in the sequence
of the choline-binding repeats are also responsible for the modular
arrangement in CbpF. Intermodular interactions are carried out
through the N-terminal module and the CI domain. Lys 90 is at a
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Fig 1 | Three-dimensional structure of CbpF in complex with choline.
(A) The stereo view of the backbone of CbpF with the amino-terminal
module in green, the CI domain in blue and CII domain in orange.
Individual choline molecules bound to the choline-binding sites are
drawn as space-filled models. (B) Complete sequence of CbpF.
Comparison of the amino-acid sequence composition of the choline-
binding repeats. Canonical repeats are labelled as p and modified repeats
are dp. Amino acids folded in b-strands are shown in bold. (C) The
stereo view of the Ca superimposition of all choline-binding repeats.
Canonical choline-binding repeats p1–p5 and also modified repeats dp1
and dp2 are shown in green, dp3 in orange, dp4 in grey, dp6 in light
blue, and dp5 in red. R.m.s.d. values among p1–p5 repeats range from
0.30 to 0.70 A˚; greater differences are observed between canonical and
modified repeats (0.44 to 1.02 A˚, as obtained by the superimposition of
the p1 repeat on the dp1–dp6 repeats). CbpF, choline-binding protein F.
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salt bridge interaction distance of Asp 89 (3.37 A˚), and Lys 96
connects the N-terminal module and the CBM (Fig 2B).
CbpF modulates the autolytic function of LytC
A highly sensitive and reliable method with radioactive pneumo-
coccal cell wall as a substrate has been implemented to detect
lytic activities of the pneumococcal cell wall. By using this assay,
CbpF did not show any lytic activity, indicating that it is unlikely
that CbpF has such enzymatic activity. Nevertheless, we tested
whether CbpF could affect the activity of the known pneumo-
coccal murein hydrolases (LytA, LytB, LytC and Pce). We assumed
that CbpF could modulate the cell wall hydrolytic activities of
these enzymes either by competing for the choline-binding sites or
for their substrate or by interacting with their catalytic or binding
modules. To test this hypothesis, we determined the in vitro cell
wall lytic activity of different murein hydrolases in the presence of
CbpF or the isolated homologous CBM of LytA (C-LytA). The
results showed that LytA, LytB and Pce activities were not
essentially affected by the addition of CbpF, but that the activity
of the LytC lysozyme was reduced in the presence of 200 nM CbpF
(supplementary Fig S2 online). To investigate the possible
individual contribution of the isolated modules of CbpF to this
inhibitory effect, N-CbpF- (containing the first 192 amino acids) or
C-CbpF- (containing the CII domain; supplementary information
online) truncated proteins were used in a similar radioactive
in vitro experiment. C-CbpF did not alter the enzymatic activity of
LytC, suggesting that the N-terminal domain of CbpF might be
crucial in this specific inhibition. Nevertheless, the presence of the
anchoring module of CbpF is required for its inhibitory function,
because the isolated N-CbpF was unable to inhibit the LytC
activity (Fig 3A). These observations preclude the possibility that
the inhibitory effect of CbpF on LytC could simply be ascribed to a
competition for binding of choline residues of the cell surface, but
the binding to choline residues is crucial to keep the CbpF protein
in close contact with the cell wall. Although the N-CbpF is able to
bind to the peptidoglycan (see below), this interaction seems too
weak to prevent the access of LytC to the substrate. This result
agrees with the behaviour of other CBP murein hydrolases, in
24222086420
Time (h)
Time (h)
Time (h)
0
0.2
0.4
0.6
0.8
O
D
55
0
O
D
55
0
O
D
55
0
24222086420
0
0.2
0.4
0.6
0.8
24222086420
0.8
0.6
0.4
0.2
0
Cpl-7Cpl-1LytC
0
20
40
60
80
100
120
A
ct
iv
ity
 (%
)
A
C D
B
Fig 3 | Inhibitory effect of CbpF on LytC hydrolytic activity. (A) In vitro
cell wall lytic activity of LytC, Cpl-1 and Cpl-7 enzymes without CbpF
(black bars), with addition of 0.2 mM CbpF (white bars), 0.2mM C-LytA
(grey bars), 0.2 mM C-CbpF (hatched bars) or 0.2 mM N-CbpF (dotted
bars). The error bar is estimated as a triple of the standard deviation
(n¼ 5 experiments). (B) Growth curves of R6lytA (closed diamonds) and
R6lytAcbpF (open triangles) strains at 30 1C. (C) Sensitization of the
R6lytA strain by externally added, purified proteins, at 1.2 mM final
concentration. An exponentially growing culture (OD550=0.2), at 30 1C,
of the R6lytA strain had CbpF (open triangles), C-CbpF (open circles),
C-LytA (open squares), or LytB (open diamonds) added. The growth
curve of an untreated culture of R6lytA (closed diamonds) is also shown.
(D) The effect of different proteins on LytC activity assayed in a culture
of R6lytAlytC strain by externally added purified proteins, at 1.2mM final
concentration. An exponentially growing culture (OD550=0.2), at 30 1C,
of the R6lytAlytC strain had LytC (open diamonds), LytCþCbpF (open
triangles), LytCþC-CbpF (open circles), or LytCþLytB (open squares)
added. The growth curve of an untreated culture of R6lytAlytC
(closed diamonds) is also shown. R6, wild-type strain of Streptococcus
pneumoniae.
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Fig 2 | Choline-binding sites at the carboxy- and amino-terminal modules.
(A) Stereo view of the choline molecule bound to a canonical choline-
binding site, showing its Fo-Fc electron density omit map contoured at
3s (green). (B) At the N-terminal module, only one pocket presents
all residues required for choline binding. However, Lys 96 residue is
blocking this site and establishing a network of salt bridge interactions
crucial in the modular arrangement of CbpF.
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which the absence of the CBM reduces their functional activity to
practically undetectable levels (Sanz et al, 1992).
To test whether the inhibitory effect of CbpF could affect other
pneumococcal lysozymes and to confirm that this effect was not
due to a binding competition for choline residues of cell wall, we
assayed the pneumococcal phage lysozymes Cpl-1 and Cpl-7.
Despite only the three-dimensional structure of Cpl-1 having been
reported, sequence and biochemical analyses show that although
the catalytic modules of both phage lysozymes are similar, the
anchoring modules are completely different (Cpl-7 does not bind
to choline; Garcı´a et al, 1990). Notably, both enzymes were
inhibited by CbpF (Fig 3A), suggesting that the inhibitory effect is
not limited to the LytC lysozyme and that the effect is not due to
competition for choline residues.
As the LytC lysozyme is involved in the autolysis of
pneumococcal cultures at 30 1C (Garcı´a et al, 1999), we used
this property to investigate the role of CbpF in vivo. Therefore, we
analysed the effect on autolysis of the absence or exogenous
addition of CbpF in R6lytAcbpF, a double frameshift/insertion
mutant of the wild-type R6 S. pneumoniae strain. The mutant was
LytA-deficient to avoid the effect of this principal autolysin on the
autolytic role of LytC at 30 1C. The slow autolysis curve for R6lytA
(Lo´pez et al, 1986), a single frameshift mutant of R6, at 30 1C was
accelerated in the R6lytAcbpF strain (Fig 3B), suggesting that the
absence of CbpF facilitates the autolytic process by LytC. This
result agrees with the repression effect of LytC by CbpF observed
in vitro, indicating that CbpF has the same regulatory function in
vivo. Furthermore, when we analysed the growth of the R6lytA
strain in the presence of CbpF added to the bacterial growth
(i.e. the surface), we observed that the addition of 1.2 mM CbpF
abolished LytC-induced autolysis at 30 1C, whereas the addition
of the truncated proteins C-CbpF or C-LytA did not alter the
autolytic curve (Fig 3C). The culture containing exogenous CbpF
showed the presence of typical unlysed R6lytA cells with a
short-chain cell morphology under phase-contrast microscopy,
whereas many lysed cells were observed in the culture without
CbpF, indicating that CbpF protects the cell wall from lytic
damage (data not shown).
Conversely, we tested the behaviour of R6lytAlytC, a double
frameshift/insertion mutant, in the presence of LytC alone or LytC
plus CbpF (Fig 3D). As expected, the mutant cells autolysed when
they received a defined quantity of LytC (Garcı´a et al, 1999);
however, the autolysis was circumvented when LytC was added in
the presence of 1.2 mM of CbpF. It is worth noting that the
inhibition of this autolytic process did not take place in the
presence of similar amounts of C-CbpF or other homologous
proteins such as LytB.
Taken together, all these results argue that CbpF selectively
modulates the autolytic function of the LytC lysozyme and that the
divergent choline-binding repeats that build its N-terminal domain
have a crucial function in this effect. It is well established that
autolysins have various fundamental roles in bacterial physiology
and pathology (Gosink et al, 2000; Lo´pez et al, 2004). These
catalytically competent enzymes are able to hydrolytically change
the integrity of the cell wall of the bacterium itself. The effect of
uncontrolled reactions catalysed by these enzymes could be
detrimental, and as such the enzymic activity must be tightly
regulated. The nature of this regulatory process remains unknown,
although there might be some contribution by the lipoteichoic
acid in the cell membrane (Ho¨ltje & Tomasz, 1975). Recently,
the involvement of small non-coding RNAs in the control of
stationary-phase autolysis has also been suggested (Halfmann
et al, 2007). Our results show that CbpF can inhibit the activity of
LytC both in vitro and in vivo and, therefore, we assert that CbpF is
crucial in the regulation of the activity of LytC.
The N-terminal module and peptidoglycan interaction
Initial experiments to investigate a possible direct LytC–CbpF
interaction, carried out by surface plasmon resonance and
crosslinking tests, were negative. Therefore, the observed inhibi-
tion caused by CbpF on pneumococcal lysozymes could be due to
specific interactions between CbpF and peptidoglycan, preventing
access of the lysozyme to its substrate. To study this hypothesis,
we analysed these interactions by using surface plasmon
resonance—immobilizing cell walls from Micrococcus lysodeik-
ticus and from S. pneumoniae with and without choline. As
expected, CbpF was able to bind tightly to the pneumococcal
choline-containing cell wall. Interestingly, CbpF was also able to
bind to the cell wall from S. pneumoniae without choline and, to a
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Fig 4 | Analyses of surface plasmon resonance binding. (A) Binding
curves of CbpF protein to immobilized, purified samples of bacterial
cell walls: Micrococcus lysodeikticus (1), non-choline Streptococcus
pneumoniae (2) and choline S. pneumoniae (3). (B) Binding curves of
C-LytA (1), C-CbpF (2) and N-CbpF (3) to non-choline immobilized
S. pneumoniae cell wall. The leftmost arrow in each graph indicates
injection of 2.7mM protein in 0.1M Tris–HCl pH 8.0 containing 38.5mM
choline buffer; the three right-hand arrows in each graph indicate
injection of the same buffer without protein.
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lesser extent, the cell wall of M. lysodeikticus, a standard
Gram-positive bacterial peptidoglycan that does not contain
choline (Fig 4A). Furthermore, truncated C-CbpF and C-LytA
proteins were not able to bind to the pneumococcal cell wall
without choline, suggesting that their binding capacity is restricted
to their specific interaction with this amino-alcohol (Fig 4B).
Notably, the isolated N-CbpF was able to bind to the pneumo-
coccal cell wall without choline, suggesting that N-CbpF is able to
specifically recognize the pneumococcal cell wall and that the
N- and C-terminal modules of CbpF bind to different components
of the peptidoglycan.
The N-terminal module of CbpF shows a markedly different
three-dimensional structure from the CBM. Electrostatic potential
on the surface is also different in the two modules.
Docking analyses have shown that pneumococcal peptidogly-
can can be accommodated perfectly at the N-terminal cavity of
CbpF (Fig 5), reinforcing the hypothesis that CbpF might act by
blocking the access of LytC to its substrate. A fragment of the
peptidoglycan ([GlcNAc-MurNAc-(L-Ala-gD-Glu-L-Lys-D-Ala-D-
Ala)]2) (2S5P)2 interacts with aromatic and hydrophobic residues
of the cleft (Tyr 35, Tyr 48, Trp 75, Pro 153 and Leu 154) and with
polar residues (Asp 38, Glu 50 and Asn 152; supplementary Table
S2 online). Crystallization trials failed to provide direct informa-
tion on peptidoglycan binding at the CbpF N-terminal module.
Native crystals fractured when put in contact with the synthetic
cell wall fragment, and only in one case with a rapid soak could a
diffraction data set be collected (supplementary Table S1 online).
Despite the absence of electron density for peptidoglycan,
the presence of the ligand caused a significant alteration of the
CbpF structure at the CI domain and at the N-terminal module
(supplementary Fig S1 online). Long loops of the CI domain
of the complexed structure are highly disordered and it was not
possible to trace even the backbone between residues 168 and
178. The N-terminal module in the presence of the peptidoglycan
analogue rotated B10 1 around a molecular hinge between the
N-terminal module and the linker region, leading to large
differences in the relative positions between the modules, and
further supporting a direct interaction between the peptidoglycan
and the N-terminal module.
CbpF heads a protein family of unknown function
A study of the CbpF orthologues in other pneumococcal strains
has showed the existence of proteins CbpC and CbpJ in the
TIGR4 strain (supplementary Figs S3 and S4 online). Notably,
a comparative analysis of the genes that encode these proteins
shows that cbpF might have resulted from the recombination of
cbpC and cbpJ. The coexistence of two highly similar genes in the
TIGR4 strain indicates that the corresponding encoded CbpF-like
proteins have a crucial physiological function and that this
duplication might favour the acquisition of more selective
regulatory properties.
Further analyses of known pneumococcal genomes show the
existence of several proteins that are likely to show the same
architecture as CbpF. These proteins might constitute a new CbpF-
like subfamily, within the large CBP family of proteins, that have a
typical CBM and an N-terminal region formed by a series of non-
consensus repeats. Despite the minor differences in amino-acid
composition among all the members of the CbpF-like subfamily,
most of the residues involved in both the N-terminal structural
framework and in the intermodular interactions are preserved,
indicating that these proteins might have similar regulatory
functions to CbpF.
Concluding remarks
We have disclosed the structure and fold for CbpF, which is
unique among the other functional domains of CBPs so far
determined. This structure and the new bifunctional regulatory
role that we have documented for CbpF open future avenues of
research into the characterization of other pneumococcal
members of this new subfamily of CBPs, the structure and
function of which remain unknown.
METHODS
Purification, crystallization and in vitro assays. CbpF was
produced, purified and crystallized as described earlier (Molina
et al, 2007). Detailed information about in vitro assays is
described in the supplementary information online.
Structure determination. A gadolinium derivative and a data set
at the peak of the Gd LIII absorption edge were obtained. SAD
data were collected from frozen crystals at 100K using a charged
couple detector on beamline ID29 at the European Synchrotron
Radiation Facility (ESRF). Data processing and structure determi-
nation is described in the supplementary information online.
Docking studies. The docking studies were carried out with the
FlexiDock module of the SYBYL 6.9 suite of programs (Tripos Inc.,
St Louis, MO, USA). Detailed information about docking protocols
is described in the supplementary information online.
Coordinates. The structure of CbpF–choline and CbpF–(2S5P)2
complexes have been deposited in the Protein Data Bank
(accession codes 2v04 and 2vyu).
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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